LOOKING BACK & AHEAD Another challenging year is coming to an end, but amid the difficulties have been great developments in the industry. We hear from brand leaders about their highlights of 2021, and what we can look forward to in 2022.
Iola Ciavarra, Director Reveal Pty Ltd Our highlights of 2021:
2021 was another technological breakthrough year for Revision Skincare with the introduction of Revox Line Relaxer. A potent, targeted serum designed to be paired with neuromodulators to dramatically reduce expression lines. Another nod to the medical aesthetics industry with visible and statistically significant outcomes in double blinded, placebocontrolled studies. Dramatic results are seen with, or without neuromodulators. Recent developments locally have been the introduction of myself as Director of Reveal, Revision’s new distribution partner with existing distributor EnVogue Skin. With 25+ years’ experience in the aesthetics space, I help support clinics in offering superior outcomes for their clients that work with their existing treatments and operations. With the philosophy of simplicity, flexibility and results, the partnership is refreshingly standing out from the skincare crowd already.
A sneak-peek into 2022:
2022 will see to a broader offering of digital promotional and educational support for Revision stockists that tie in with current and future trends. Technological innovations will see the launch of two new products in the retail line as well as innovative packaging updates to existing key sellers. We promise an exciting year ahead! envogueskin.com.au
Catherine Biedermann, Managing Director Advanced Cosmeceuticals Our highlights of 2021:
“2022 will see the company continue to introduce new packaging and the brand’s refresh.”
2021 has seen expanded growth for Advanced Cosmeceuticals with some exciting new skincare and device brands joining our portfolio including Plasma Pen and HyaPen Pro by Louise Walsh International, innovator of one of the world’s most advanced suite of non-invasive, nitrogen plasma devices. Barcelona based Cocoon Medical joined our portfolio with innovative energy-based devices including Primelase, Elysion-Pro and second generation Cooltech Define. Lutronic launched HOLLYWOOD SPECTRA™, building upon the world’s leading 1064/532nm laser platform. Pushing boundaries of efficacy, skincare brand SkinMTX provides high potency formulations for in-clinic, postprocedure home care and special care. Stateof-the-art needle-free biorevitalisation, WiQo
is a lifting and brightening programme applied in-clinic with a home care protocol, and finally, scientifically advanced, AnteAGE, in-clinic only, provides powerful skincare and treatments based on growth factors, stem cells and cytokines for microneedling, hair regrowth, vaginal rejuvenation and advanced anti-ageing. A sneak-peek into 2022:
With the exciting new additions to the Advanced Cosmeceuticals portfolio, 2022 will see our team concentrate on building brand awareness of our new skincare and device brands within the industry and working with clinic partners in terms of education and training. This will, of course, be in conjunction with the continued focus on working with our existing brands and their launches. mesoestetic introduced their new brand positioning in 2021, ‘the element for skincare experts’ so 2022 will see the company continue to introduce new packaging and the brand’s refresh. We hope 2022 will see the return of conferences, events and face to face trainings – something I’m sure we all look forward to. advancedcosmeceuticals.com.au
24 | SPA+CLINIC